Research Briefs

Date of this Version

6-4-2018

Abstract

Post-angioplasty, patient adherence to recommended antiplatelet therapy decreased when newer, more expensive drugs were introduced. From 2008-2016, as the use of newer agents increased, the proportion of patients not filling any antiplatelet prescription within 30 days of discharge increased from 6.4% to 19.1%. In the subsequent 12 months, the newer drugs were associated with higher patient costs and lower adherence to recommended therapy.

Document Type

Brief

Number

43

License

Creative Commons License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.

Keywords

medication adherence, angioplasty, antiplatelet therapy, health disparities

Citation For This Study

Dayoub EJ, Seigerman M, Tuteja S, et al. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among AntiplateletNaive Patients After Percutaneous Coronary Intervention, 2008-2016. JAMA Intern Med. Published online May 21, 2018. doi:10.1001/jamainternmed.2018.0783

Share

COinS
 

Date Posted:04 June 2018